Oragenics, Inc. (OGEN) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

+319.2%

$1.56

vs $0.37 price

Levered DCF

$1.93

After debt service

Piotroski score

1 / 9

Weak

Altman Z-score

-63.79

Distress zone

Rating

C+

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	-0.17×	-6.93×	-18.4×	-26.61×	-99.23×	-28.81×	-42.6×	-33.89×
P/B	0.2×	-346.28×	119.95×	29.21×	57.04×	45.21×	38.5×	16.09×
P/S	0×	0×	0×	0×	0×	0×	0×	0×
EV / EBITDA	-0×	-6.91×	-18.3×	-25.95×	-94.82×	-28.01×	-41.7×	-31.98×
Gross margin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Operating margin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net margin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Current ratio	5.64×	0.87×	2.15×	8.95×	19.17×	13.4×	10.18×	18.79×
Debt / equity	0.03×	-1.55×	0.1×	0.05×	0.03×	0.05×	0.06×	0.01×
Interest coverage	-11.91×	-353.99×	-683.37×	-954.83×	-1,000.95×	-2,493.35×	-2,175.07×	-1,727.27×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.1%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	-7.1%	0.0%	0.0%	-0.6%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	-118.9%	4987.6%	-652.0%	-109.8%	-59.3%	-156.9%	-90.4%	-47.5%
Return on invested capital	-108.5%	-9052.2%	-598.9%	-105.8%	-57.8%	-150.1%	-87.2%	-47.2%
Return on assets	-97.8%	-717.7%	-415.9%	-96.8%	-55.7%	-141.5%	-78.8%	-45.0%
Free cash flow yield	-547310.7%	-11.7%	-2.2%	-4.0%	-0.9%	-2.2%	-2.0%	-2.7%
Earnings yield	-582.6%	-14.4%	-5.4%	-3.8%	-1.0%	-3.5%	-2.3%	-3.0%
Enterprise value	-$2.5M	$72.8M	$376.9M	$369.3M	$1.5B	$744.7M	$646.1M	$315.9M
Net debt / EBITDA	-0.01×	0.05×	0.15×	0.76×	1.69×	0.63×	1.12×	2.03×
Cash conversion cycle (days)	0	0	0	0	0	-5	-7,036	-10,046